J&J to purchase Abbott’s vision care assets
JOHNSON & Johnson has reached a deal to buy opthalmic assets from Abbott Laboratories for US$4.3 billion as it targets vision care in an aging world.
J&J will acquire Abbott Medical Optics, which works in three areas: cataract surgery, laser vision surgery (LASIK) and consumer items such as contact solution and eye drops. AMO had sales of $1.1 billion in 2015.
“Eye health is one of the fastest growing segments in healthcare today,” said Ashley McEvoy, who leads J&J’s vision care division. –